Elevated serum interleukin-6 predicts favorable response to immunosuppressive therapy in children with aplastic anemia
Journal of Pediatric Hematology/Oncology Nov 01, 2017
Lu S, et al. - This trial was conducted in order to ascertain if the serum interleukin-6 (IL-6) speculated a favorable response to immunosuppressive therapy (IST) in children with aplastic anemia (AA). A favorable response was predicted via high levels of IL-6 at the time of diagnosis. This data could be beneficial for patientÂs stratification and clinical decisions.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
